| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/01/2007 | US20070048388 Stabilized and preserved ketotifen ophthalmic compositions |
| 03/01/2007 | US20070048386 Medicament for treating inflammatory and non-inflammatory arthritis |
| 03/01/2007 | US20070048384 Pharmaceutical compositions |
| 03/01/2007 | US20070048382 for use in spinal surgery; spray-dried hydroxyapatite, radical donor (benzoyl peroxide) and polymethyl methacrylate |
| 03/01/2007 | US20070048380 Use of an oral dosage with quick release and storage stability: core of omeprazole, lansoprazole or pantoprazole and adjuvants; an intermediate layer having a gastric juice-resistant partially alkali neutralized polymer with cation exchange capacity, and an outer gastric juice resistant layer |
| 03/01/2007 | US20070048378 Nanoparticulate anticonvulsant and immunosuppressive compositions |
| 03/01/2007 | US20070048376 Sustained release formulations of nalbuphine |
| 03/01/2007 | US20070048375 Effervescent preparation of a basic medicinally active substance |
| 03/01/2007 | US20070048374 Bazedoxifene acetate formulations |
| 03/01/2007 | US20070048373 Dried milled granulate and methods |
| 03/01/2007 | US20070048372 Method for treating non-inflammatory osteoarthritic pain |
| 03/01/2007 | US20070048371 Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily |
| 03/01/2007 | US20070048370 Pharmaceutical formulation for salts of monobasic acids with clopidogrel |
| 03/01/2007 | US20070048369 Mucosal delivery tablet |
| 03/01/2007 | US20070048367 Herbal composition for treating morning sickness |
| 03/01/2007 | US20070048363 chemotherapeutical agent comprising cis-diammoniumdichloro-trans-dihydroxoplatinum(IV) or salts and/or derivatives thereof in the form of capsules, tablets, creams, ointments and infusion solutions; antitumor agents |
| 03/01/2007 | US20070048358 Antimicrobial substrates |
| 03/01/2007 | US20070048356 Antimicrobial treatment of nonwoven materials for infection control |
| 03/01/2007 | US20070048355 Non-irritating solvent-borne polymeric coatings for application to the skin |
| 03/01/2007 | US20070048354 Synthetic nutritional formulations |
| 03/01/2007 | US20070048351 Drugs coated on a device to treat vulnerable plaque |
| 03/01/2007 | US20070048350 Antithrombotic coating for drug eluting medical devices |
| 03/01/2007 | US20070048343 Biocidal premixtures |
| 03/01/2007 | US20070048338 Compositions and methods for surface treatment in medical and surgical procedures |
| 03/01/2007 | US20070048336 Combination therapy of peptide vaccination and estramustine treatment |
| 03/01/2007 | US20070048335 Methods for treating pain and hyperhidrosis |
| 03/01/2007 | US20070048330 Optimized multi-epitope constructs and uses thereof |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048299 Methods of inducing an immune response |
| 03/01/2007 | US20070048296 Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation |
| 03/01/2007 | US20070048288 Shear thinning polymer cell delivery compositions |
| 03/01/2007 | US20070048286 Method of treating dopaminergic and GABA-nergic disorders |
| 03/01/2007 | US20070048284 Cardiac arrhythmia treatment methods |
| 03/01/2007 | US20070048283 Exposing to immunogenic portion of protein and/or encoding nucleotide homologenous to sequence 20 or 22b; eliciting response to 74P3B3 protein; pancreatic cancer |
| 03/01/2007 | US20070048252 Conjugates of the hydrophilic polymer and the molecules from boxwood extraction, and pharmaceutical compositions of the conjugates |
| 03/01/2007 | US20070048251 Methods for sealing an orifice in tissue using an aldol-crosslinked polymeric hydrogel adhesive |
| 03/01/2007 | US20070048250 Methods of treating concomitant constipation in a cancer treatment regimen including imexon |
| 03/01/2007 | US20070048249 Hydrophilized bactericidal polymers |
| 03/01/2007 | US20070048247 Deodorizing tablets |
| 03/01/2007 | US20070048234 Compositions and methods for treating acne |
| 03/01/2007 | US20070048233 Artificial tanning composition containing medication |
| 03/01/2007 | US20070048231 Pheromone compositions and methods |
| 03/01/2007 | US20070048230 Pheromone compositions and methods |
| 03/01/2007 | US20070048229 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant; blocking effects of acetylcholine at muscarine receptors |
| 03/01/2007 | US20070048228 Heat pressing a mixture of an active ingredient with abuse potential, a high strength polymer, and a wax into a controlled release dosage form |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048218 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | US20070048215 Chemical compound and assay |
| 03/01/2007 | US20070044795 Method and apparatus for dispensing inhalator medicament |
| 03/01/2007 | DE20122679U1 Behandlung von Knochenerkrankungen Treatment of bone diseases |
| 03/01/2007 | DE19831579B4 Antikrebstherapiemittel aus Arsenhexoxid Anti-cancer therapeutics from Arsenhexoxid |
| 03/01/2007 | DE10308864B4 Neues Brauverfahren, damit gebrautes Bier und dessen Verwendung New brewing process, thus brewed beer and its use |
| 03/01/2007 | DE102005040841A1 Combination preparation, useful for the treatment of e.g. hypertonia, comprises thiazide diuretic, preferably hydrochlorothiazide and a loop diuretic, preferably torseamide, as active substances |
| 03/01/2007 | DE102005039066A1 New indazole squaric acid compounds are checkpoint kinase-1 modulators, useful to treat or prevent e.g. cancer, diabetes mellitus, microangiopathy, glaucoma, cataract, bacterial infections, cell aging, stress, and arteriosclerosis |
| 03/01/2007 | CA2816276A1 Balsalazide formulations and manufacture and use thereof |
| 03/01/2007 | CA2799529A1 Novel sulfonamides |
| 03/01/2007 | CA2661448A1 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow |
| 03/01/2007 | CA2621164A1 Derivative having ppar agonistic activity |
| 03/01/2007 | CA2621158A1 N-oxides as prodrugs of piperazine & piperidine derivatives |
| 03/01/2007 | CA2620847A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma. |
| 03/01/2007 | CA2620835A1 Delta and epsilon crystal forms of imatinib mesylate |
| 03/01/2007 | CA2620447A1 Combinations comprising dmxaa for the treatment of cancer |
| 03/01/2007 | CA2620436A1 Combinations comprising dmxaa for the treatment of cancer |
| 03/01/2007 | CA2620418A1 Benztropine compounds and uses thereof |
| 03/01/2007 | CA2620346A1 Control of induced elevated intraocular pressure |
| 03/01/2007 | CA2620333A1 Neurogenesis by muscarinic receptor modulation |
| 03/01/2007 | CA2620281A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma |
| 03/01/2007 | CA2620275A1 Non-steroidal antiandrogens |
| 03/01/2007 | CA2620259A1 Sustained-release preparation |
| 03/01/2007 | CA2620257A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2620254A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2620202A1 Therapy procedure for drug delivery for trigeminal pain |
| 03/01/2007 | CA2620183A1 Agents for preventing and treating disorders involving modulation of the ryr receptors |
| 03/01/2007 | CA2620182A1 Tlr agonists |
| 03/01/2007 | CA2620174A1 Bazedoxifene acetate formulations and manufacturing process thereof |
| 03/01/2007 | CA2620173A1 Alpha2c adrenoreceptor agonists |
| 03/01/2007 | CA2620171A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 03/01/2007 | CA2620124A1 Diazaspirodecane orexin receptor antagonists |
| 03/01/2007 | CA2620106A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2620105A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2620104A1 Fused pyrazole as p38 map kinase inhibitors |
| 03/01/2007 | CA2620091A1 Balsalazide formulations and manufacture and use thereof |
| 03/01/2007 | CA2620090A1 Use of azabicyclo hexane derivatives |
| 03/01/2007 | CA2620052A1 Indenoisoquinolinone analogs and methods of use thereof |
| 03/01/2007 | CA2620032A1 Polymer conjugates of k-252a and derivatives thereof |
| 03/01/2007 | CA2620026A1 Method for production of single- and multi-layer microcapsules |
| 03/01/2007 | CA2620024A1 Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain |
| 03/01/2007 | CA2619992A1 Cleavage of antifolate compounds |
| 03/01/2007 | CA2619972A1 Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use |
| 03/01/2007 | CA2619889A1 Hedgehog pathway antagonists to treat disease |
| 03/01/2007 | CA2619863A1 Use of ambroxol for the treatment of rhinovirus infections |
| 03/01/2007 | CA2619856A1 Use of sodium channel blockers for the treatment of visceral pain or pain caused by cancer treatment |
| 03/01/2007 | CA2619851A1 3-oxo-indazole-squaric acid derivatives |
| 03/01/2007 | CA2619834A1 Stabilized and preserved ketotifen ophthalmic compositions |
| 03/01/2007 | CA2619770A1 Phenylpyridone derivative |
| 03/01/2007 | CA2619715A1 Pharmaceutical compositions with melting point depressant agents and method of making same |
| 03/01/2007 | CA2619668A1 Use of sodium channel blockers for the management of musculoskeletal pain |
| 03/01/2007 | CA2619660A1 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 03/01/2007 | CA2619582A1 Stabilized and preserved ketotifen ophthalmic compositions |